lactic acid has been researched along with Acute Coronary Syndrome in 11 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Therapy refractory cardiogenic shock is associated with dismal outcome." | 1.40 | Percutaneous extracorporeal life support for patients in therapy refractory cardiogenic shock: initial results of an interdisciplinary team. ( Born, F; Fischer, M; Guenther, S; Hagl, C; Khaladj, N; Massberg, S; Peterss, S; Pichlmaier, M; Sattler, S; Theiss, HD, 2014) |
| "Acute cardiogenic shock or cardiac arrest (CS/CA) before cardiopulmonary bypass (CPB) installation are life-threatening events in acute coronary syndromes." | 1.35 | Continuous coronary sinus perfusion reverses ongoing myocardial damage in acute ischemia. ( Costanzo, FS; Cristodoro, L; Onorati, F; Renzulli, A; Santarpino, G; Scalas, C, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Tindale, A | 1 |
| Panoulas, V | 1 |
| Liang, D | 1 |
| Zhou, X | 1 |
| Hong, X | 1 |
| Feng, X | 1 |
| Shan, P | 1 |
| Xie, Q | 1 |
| Xu, T | 1 |
| Cai, M | 1 |
| Zhou, J | 1 |
| Wang, S | 2 |
| Huang, W | 1 |
| Guenther, S | 1 |
| Theiss, HD | 1 |
| Fischer, M | 1 |
| Sattler, S | 1 |
| Peterss, S | 1 |
| Born, F | 1 |
| Pichlmaier, M | 1 |
| Massberg, S | 1 |
| Hagl, C | 1 |
| Khaladj, N | 1 |
| Wiebe, J | 1 |
| Nef, HM | 1 |
| Hamm, CW | 1 |
| Reiss, S | 1 |
| Krafft, AJ | 1 |
| Zehender, M | 1 |
| Heidt, T | 1 |
| Pfannebecker, T | 1 |
| Bode, C | 1 |
| Bock, M | 1 |
| von Zur Muhlen, C | 1 |
| di Grezia, F | 1 |
| di Panzillo, EA | 1 |
| Russo, S | 1 |
| Gargiulo, G | 1 |
| Della-Morte, D | 1 |
| Testa, G | 1 |
| Cacciatore, F | 1 |
| Bonaduce, D | 1 |
| Abete, P | 1 |
| Rigamonti, F | 1 |
| Montecucco, F | 1 |
| Boroli, F | 1 |
| Rey, F | 1 |
| Gencer, B | 1 |
| Cikirikcioglu, M | 1 |
| Reverdin, S | 1 |
| Carbone, F | 1 |
| Noble, S | 1 |
| Roffi, M | 1 |
| Banfi, C | 1 |
| Giraud, R | 1 |
| Vesga, B | 1 |
| Hernandez, H | 1 |
| Moncada, M | 1 |
| Gasior, P | 1 |
| Higuera, S | 1 |
| Dager, A | 1 |
| Arana, C | 1 |
| Delgado, JA | 1 |
| Généreux, P | 1 |
| Maehara, A | 1 |
| Granada, JF | 1 |
| Han, Y | 1 |
| Jing, Q | 1 |
| Chen, X | 1 |
| Ma, Y | 1 |
| Liu, H | 1 |
| Luan, B | 1 |
| Wang, G | 1 |
| Li, Y | 1 |
| Wang, Z | 1 |
| Wang, D | 1 |
| Xu, B | 1 |
| Gao, R | 1 |
| Weber, U | 1 |
| Reitinger, A | 1 |
| Szusz, R | 1 |
| Hellmich, C | 1 |
| Steinlechner, B | 1 |
| Hager, H | 1 |
| Mora, B | 1 |
| Selzer, M | 1 |
| Hiesmayr, M | 1 |
| Kober, A | 1 |
| Onorati, F | 1 |
| Santarpino, G | 1 |
| Cristodoro, L | 1 |
| Scalas, C | 1 |
| Costanzo, FS | 1 |
| Renzulli, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multicenter, Randomized, Non-inferiority Study of Firebird 2 Versus Excel Sirolimus-eluting Stent in Treating Real-world Patients With Coronary Artery Disease[NCT01373632] | Phase 4 | 570 participants (Anticipated) | Interventional | 2011-06-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for lactic acid and Acute Coronary Syndrome
| Article | Year |
|---|---|
Current status of bioresorbable scaffolds in the treatment of coronary artery disease.
Topics: Absorbable Implants; Acute Coronary Syndrome; Coronary Angiography; Coronary Artery Disease; Humans; | 2014 |
10 other studies available for lactic acid and Acute Coronary Syndrome
| Article | Year |
|---|---|
The BE-ALIVE score: assessing 30-day mortality risk in patients presenting with acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Algorithms; Hospitalization; Hospitals; Humans; Lactic Acid | 2023 |
Association between admission lactate levels and mortality in patients with acute coronary syndrome: a retrospective cohort study.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Cause of Death; China; Female; Follow-Up Studies; Hospita | 2019 |
Percutaneous extracorporeal life support for patients in therapy refractory cardiogenic shock: initial results of an interdisciplinary team.
Topics: Acute Coronary Syndrome; Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Cardiomyopathies; E | 2014 |
Magnetic resonance imaging of bioresorbable vascular scaffolds: potential approach for noninvasive evaluation of coronary patency.
Topics: Acute Coronary Syndrome; Aged; Biocompatible Materials; Blood Vessel Prosthesis Implantation; Corona | 2015 |
Prognostic role of lactate on mortality in younger and older patients with cardio-respiratory failure admitted to an acute intensive care unit.
Topics: Acidosis, Lactic; Acute Coronary Syndrome; Aged; Female; Hospital Mortality; Hospitalization; Humans | 2016 |
The peak of blood lactate during the first 24h predicts mortality in acute coronary syndrome patients under extracorporeal membrane oxygenation.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Extracorporeal Membrane Oxygenation; Female; Follow-Up St | 2016 |
Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study.
Topics: Absorbable Implants; Acute Coronary Syndrome; Aged; Cardiovascular Agents; Chromium; Coronary Angiog | 2017 |
Long-term clinical, angiographic, and intravascular ultrasound outcomes of biodegradable polymer-coated sirolimus-eluting stents.
Topics: Absorption; Acute Coronary Syndrome; Adult; Aged; Aged, 80 and over; Aspirin; Coated Materials, Bioc | 2008 |
Emergency ambulance transport induces stress in patients with acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Ambulances; Blood Pressure; Epinephrine; Heart Rate; Humans; Lactic A | 2009 |
Continuous coronary sinus perfusion reverses ongoing myocardial damage in acute ischemia.
Topics: Acute Coronary Syndrome; Aged; Biomarkers; Cardiopulmonary Bypass; Cardiotonic Agents; Coronary Arte | 2009 |